Literature DB >> 28337285

Preclinical and clinical evaluation of the liver tumor irreversible electroporation by magnetic resonance imaging.

Matteo Figini1, Xifu Wang1, Tianchu Lyu1, Zhanliang Su1, Daniele Procissi1, Vahid Yaghmai2, Andrew C Larson2, Zhuoli Zhang2.   

Abstract

Irreversible electroporation (IRE) is a relatively new technique for tumor ablation. It has shown promising results in difficult cases where surgery is not recommended and delicate anatomic structures are present near or within the tumor. Currently, liver cancer is one of the most common targets for IRE treatment. Pre-operative and post-operative imaging has a key role in IRE procedures and research studies. Although ultrasound is usually the first choice, especially for intra-operative guidance, magnetic resonance imaging (MRI) plays an important role in the visualization and characterization of tumor before and after IRE in clinical and preclinical studies. However, the appearance of liver lesions after IRE with different MRI sequences has never been systematically investigated, and the most common practice is to limit the acquisition protocol to only contrast-enhanced T1-weighted images. In this work, the role of MRI in clinical and preclinical assessment of hepatic tumors treated with IRE is reviewed and discussed.

Entities:  

Keywords:  Irreversible electroporation; liver; magnetic resonance imaging; therapy response

Year:  2017        PMID: 28337285      PMCID: PMC5340692     

Source DB:  PubMed          Journal:  Am J Transl Res            Impact factor:   4.060


  26 in total

1.  Percutaneous ablation therapy of hepatocellular carcinoma with irreversible electroporation: MRI findings.

Authors:  Vincenza Granata; Roberta Fusco; Orlando Catalano; Mauro Piccirillo; Mario De Bellis; Francesco Izzo; Antonella Petrillo
Journal:  AJR Am J Roentgenol       Date:  2015-05       Impact factor: 3.959

2.  Irreversible electroporation of a liver metastasis.

Authors:  Lorenzo Mannelli; Siddharth A Padia; Raymond S Yeung; Douglas E Green
Journal:  Liver Int       Date:  2012-08-26       Impact factor: 5.828

3.  Ablation of perivascular hepatic malignant tumors with irreversible electroporation.

Authors:  T Peter Kingham; Ami M Karkar; Michael I D'Angelica; Peter J Allen; Ronald P Dematteo; George I Getrajdman; Constantinos T Sofocleous; Stephen B Solomon; William R Jarnagin; Yuman Fong
Journal:  J Am Coll Surg       Date:  2012-06-16       Impact factor: 6.113

4.  Irreversible electroporation: a novel image-guided cancer therapy.

Authors:  Edward W Lee; Susan Thai; Stephen T Kee
Journal:  Gut Liver       Date:  2010-09-10       Impact factor: 4.519

5.  Irreversible electroporation of a hepatocellular carcinoma lesion adjacent to a transjugular intrahepatic portosystemic shunt stent graft.

Authors:  Christoph Niessen; Ernst Michael Jung; Walter A Wohlgemuth; Benedikt Trabold; Michael Haimerl; Andreas Schreyer; Christian Stroszczynski; Philipp Wiggermann
Journal:  Korean J Radiol       Date:  2013-08-30       Impact factor: 3.500

6.  Multimodality imaging to assess immediate response to irreversible electroporation in a rat liver tumor model.

Authors:  Yue Zhang; Sarah B White; Jodi R Nicolai; Zhuoli Zhang; Derek L West; Dong-Hyun Kim; A Lee Goodwin; Frank H Miller; Reed A Omary; Andrew C Larson
Journal:  Radiology       Date:  2014-02-18       Impact factor: 11.105

7.  Vessel patency post irreversible electroporation.

Authors:  Govindarajan Narayanan; Shivank Bhatia; Ana Echenique; Rekha Suthar; Katuzka Barbery; Jose Yrizarry
Journal:  Cardiovasc Intervent Radiol       Date:  2014-09-12       Impact factor: 2.740

8.  Irreversible Electroporation in Patients with Hepatocellular Carcinoma: Immediate versus Delayed Findings at MR Imaging.

Authors:  Siddharth A Padia; Guy E Johnson; Raymond S Yeung; James O Park; Daniel S Hippe; Matthew J Kogut
Journal:  Radiology       Date:  2015-11-02       Impact factor: 11.105

9.  Irreversible electroporation of hepatocellular carcinoma: preliminary report on the diagnostic accuracy of magnetic resonance, computer tomography, and contrast-enhanced ultrasound in evaluation of the ablated area.

Authors:  Vincenza Granata; Elisabetta de Lutio di Castelguidone; Roberta Fusco; Orlando Catalano; Mauro Piccirillo; Raffaele Palaia; Francesco Izzo; Adolfo D'Errico Gallipoli; Antonella Petrillo
Journal:  Radiol Med       Date:  2015-09-07       Impact factor: 3.469

10.  The efficacy and safety of irreversible electroporation for the ablation of renal masses: a prospective, human, in-vivo study protocol.

Authors:  Peter G K Wagstaff; Daniel M de Bruin; Patricia J Zondervan; C Dilara Savci Heijink; Marc R W Engelbrecht; Otto M van Delden; Ton G van Leeuwen; Hessel Wijkstra; Jean J M C H de la Rosette; M Pilar Laguna Pes
Journal:  BMC Cancer       Date:  2015-03-22       Impact factor: 4.430

View more
  4 in total

1.  Diffusion MRI biomarkers predict the outcome of irreversible electroporation in a pancreatic tumor mouse model.

Authors:  Matteo Figini; Xifu Wang; Tianchu Lyu; Zhanliang Su; Bin Wang; Chong Sun; Junjie Shangguan; Liang Pan; Kang Zhou; Quanhong Ma; Vahid Yaghmai; Daniele Procissi; Andrew C Larson; Zhuoli Zhang
Journal:  Am J Cancer Res       Date:  2018-08-01       Impact factor: 6.166

2.  Transcatheter intra-arterial perfusion (TRIP)-MRI biomarkers help detect immediate response to irreversible electroporation of rabbit VX2 liver tumor.

Authors:  Matteo Figini; Kang Zhou; Liang Pan; Chong Sun; Bin Wang; Su Hu; Jia Yang; Junjie Shangguan; Aydin Eresen; Yury Velichko; Vahid Yaghmai; Zhuoli Zhang
Journal:  Magn Reson Med       Date:  2019-12-18       Impact factor: 4.668

3.  Irreversible electroporation in patients with liver tumours: treated-area patterns with contrast-enhanced ultrasound.

Authors:  Linyu Zhou; Shanyu Yin; Weilu Chai; Qiyu Zhao; Guo Tian; Danxia Xu; Tian'an Jiang
Journal:  World J Surg Oncol       Date:  2020-11-23       Impact factor: 2.754

Review 4.  A Systematic Review about Imaging and Histopathological Findings for Detecting and Evaluating Electroporation Based Treatments Response.

Authors:  Vincenza Granata; Roberta Fusco; Simona Salati; Antonella Petrillo; Elio Di Bernardo; Roberta Grassi; Raffaele Palaia; Ginevra Danti; Michelearcangelo La Porta; Matteo Cadossi; Gorana Gašljević; Gregor Sersa; Francesco Izzo
Journal:  Int J Environ Res Public Health       Date:  2021-05-24       Impact factor: 3.390

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.